Acceleration of Medpor implant fibrovascularization with local vascular endothelial growth-factor injections: An experimental study

• Main Authors: Mert Demirel, Burak Kaya, Aylin Okcu Heper, Murat Emiroglu
• Format: Article
• Language: English
• Published: GESDAV 2015-12-01
• Series: Archives of Clinical and Experimental Surgery
• Subjects: Angiogenesis; fibrovascularization; Medpor; vascular endothelial growth factor
• Online Access: http://www.scopemed.org/fulltextpdf.php?mno=172506

Objective: Medpor is a biocompatible, high-density porous polyethylene implant that is used for multiple indications in plastic surgery. The most frequent complications associated with the Medpor implant are infection and implant exposure. The primary cause of these complications is poor fibrovascularization of the Medpor implant and poor nourishment of the overlying skin. The present experimental study aimed to determine whether vascular endothelial growth factor (VEGF) could accelerate and increase Medpor implant fibrovascularization in vivo, and thereby improve local nourishment and prevent complications. Materials and Methods: The Medpor implant was inserted under the dorsal skin area in 40 Sprague-Dawley rats. 20 rats receiving local VEGF injections comprised the study group. The control group received saline injections. Fibrovascularization of the Medpor implants was compared. Results: In the rats injected with VEGF, the Medpor implant fibrovascularized faster, and there were more newly formed blood vessels, as compared with those in the control group. Conclusion: These findings have led to our use of VEGF-like agents that the accelerate angiogenesis in the Medpor implant as a means to reduce the incidence of such complications as infection and implant exposure. [Arch Clin Exp Surg 2015; 4(4.000): 196-201]